Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Using existing drugs for new treatments is cost-effective and safer.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Exosomes could revolutionize skin disease treatment and healing.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

Women with PCOS have altered brain structure and reduced cognitive performance.

PCOS treatment should be personalized based on individual symptoms and health goals.

FUE hair transplants are generally safe but require careful planning to avoid rare complications.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

PRP therapy may help with ovarian issues and fertility, but more research is needed.